
Sign up to save your podcasts
Or


Send us a text
Nick Jikomes talks to Jeff Ubersax, PhD, CEO of the biotechnology company Demetrix (who supported this episode). Jeff discussed the science behind how Demetrix is engineering baker's yeast to produce cannabinoids at an industrial scale, with a focus on making rare cannabinoids other than THC and CBD.
Jeff also discussed how he transitioned from academic science to running his own company, and offered advice for academic scientists in training who might be thinking about moving into biotechnology.
Episode Support: This episode was supported by Demetrix, a biotechnology company using cutting edge fermentation technology to produce rare cannabinoids that are safe, legal, and effective for health and wellness.
Support the show
Affiliates:
For all the ways you can support my efforts
By Nick Jikomes4.8
8181 ratings
Send us a text
Nick Jikomes talks to Jeff Ubersax, PhD, CEO of the biotechnology company Demetrix (who supported this episode). Jeff discussed the science behind how Demetrix is engineering baker's yeast to produce cannabinoids at an industrial scale, with a focus on making rare cannabinoids other than THC and CBD.
Jeff also discussed how he transitioned from academic science to running his own company, and offered advice for academic scientists in training who might be thinking about moving into biotechnology.
Episode Support: This episode was supported by Demetrix, a biotechnology company using cutting edge fermentation technology to produce rare cannabinoids that are safe, legal, and effective for health and wellness.
Support the show
Affiliates:
For all the ways you can support my efforts

5,002 Listeners

1,532 Listeners

1,921 Listeners

309 Listeners

1,227 Listeners

372 Listeners

5,302 Listeners

666 Listeners

29,147 Listeners

243 Listeners

183 Listeners

1,194 Listeners

114 Listeners

1,075 Listeners

74 Listeners